文献速递鼻科

鼻内直接应用ImmunoCAP固相可提高局部变应性鼻炎患者鼻特异性IgE检测

Direct intranasal application of the solid phase of ImmunoCAP® increases nasal specific immunoglobulin E detection in local allergic rhinitis patients.
PubMed 文献 · Int Forum Allergy Rhinol · 2017-11-14

该研究纳入50例受试者(局部变应性鼻炎14例、变应性鼻炎20例、健康对照16例),在屋尘螨鼻激发后24小时将ImmunoCAP固相直接置于鼻腔检测鼻特异性IgE。以鼻特异性IgE≥0.1450为最佳截断值,局部变应性鼻炎灵敏度42.86%、特异度100%,变应性鼻炎灵敏度75%、特异度100%。

要点

  • 鼻激发后24小时直接鼻腔放置ImmunoCAP固相可检测鼻特异性IgE。
  • 鼻特异性IgE≥0.1450时对局部变应性鼻炎特异度达100%。
  • 该方法对局部变应性鼻炎灵敏度有限(42.86%)。

核心结论

  • 采用简单商业化装置直接鼻腔应用ImmunoCAP固相可在局部变应性鼻炎患者中检测屋尘螨鼻特异性IgE,且特异度高。

研究设计与样本

  • 研究纳入50例受试者,包括局部变应性鼻炎14例、变应性鼻炎20例、健康对照16例。
  • 在屋尘螨鼻激发后24小时,直接应用商业化屋尘螨ImmunoCAP检测的固相进行鼻特异性IgE检测。

主要发现

  • 三组间ImmunoCAP固相吸收分泌物的中位体积无差异(p=0.17)。
  • ROC曲线分析显示鼻特异性IgE≥0.1450为最佳截断值。
  • 局部变应性鼻炎患者灵敏度42.86%、特异度100%;变应性鼻炎患者灵敏度75%、特异度100%。

关键数值与推荐

  • 鼻特异性IgE最佳截断值为≥0.1450。
  • 局部变应性鼻炎:灵敏度42.86%,特异度100%。
  • 变应性鼻炎:灵敏度75%,特异度100%。

临床怎么用

  • 可为局部变应性鼻炎提供一种微创的鼻特异性IgE检测方法。
  • 高特异度有助于确认屋尘螨局部变应性鼻炎,但灵敏度有限需结合临床。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The measurement of nasal specific IgE (NsIgE) in local allergic rhinitis (LAR) patients is challenging and shows variability. The objective of this work was to evaluate a minimally-invasive method of direct detection of NsIgE in patients with LAR to Dermatophagoides pteronyssinus (DP) using an automated immunoassay. METHODS: Fifty patients participated (LAR, n = 14; allergic rhinitis (AR), n = 20; healthy controls [HC], n = 16). Detection of NsIgE was performed by direct application of the solid phase of a commercial DP ImmunoCAP® test 24 hours after DP nasal provocation. RESULTS: There was no difference in the median volume of secretion absorbed by the solid phase of the ImmunoCAP test in the 3 studied groups (p = 0.17). According to receiver operating characteristic (ROC) curve analysis, NsIgE ≥0.1450 was the optimal cutoff point, obtaining in LAR patients 42.86% sensitivity with the highest specificity (100%), and 75% sensitivity and 100% specificity for AR. CONCLUSION: This study demonstrates the detection of NsIgE to DP in LAR by using a simple, commercial device with high specificity.

来源:Int Forum Allergy Rhinol,查看原文。版权归原作者所有。

引用

  1. Campo P, Del Carmen Plaza-Seron M, Eguiluz-Gracia I, et al. Direct intranasal application of the solid phase of ImmunoCAP® increases nasal specific immunoglobulin E detection in local allergic rhinitis patients. Int Forum Allergy Rhinol. 2017. PMID: 29136342. doi:10.1002/alr.22039

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。